Treatment of IgM antibody associated polyneuropathies using rituximab (Q43069450)

13 November 2017

Treatment of IgM antibody associated polyneuropathies using rituximab (English)

1 reference

13 November 2017

1 reference

A Pestronk

1

1 reference

13 November 2017

J Florence

2

1 reference

13 November 2017

T Miller

3

1 reference

13 November 2017

R Choksi

4

1 reference

13 November 2017

M T Al-Lozi

5

1 reference

13 November 2017

T D Levine

6

1 reference

13 November 2017

language of work or name

English

0 references

publication date

1 April 2003

1 reference

Journal of Neurology, Neurosurgery and Psychiatry

13 November 2017

1 reference

13 November 2017

74

1 reference

13 November 2017

4

1 reference

13 November 2017

485-489

1 reference

Multifocal motor neuropathy: clinical and immunological features and response to IVIg in relation to the presence and degree of motor conduction block.

13 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1738397

Rituximab: mechanisms and applications

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1738397

Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura.

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1738397

Multifocal motor neuropathy.

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1738397

Multifocal motor neuropathy: long-term clinical and electrophysiological assessment of intravenous immunoglobulin maintenance treatment.

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1738397

IgM monoclonal antibody against terminal moiety of GM2, GalNAc-GD1a and GalNAc-GM1b from a pure motor chronic demyelinating polyneuropathy patient: effects on neurotransmitter release.

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1738397

CD20-Directed Antibody-Mediated Immunotherapy Induces Responses and Facilitates Hematologic Recovery in Patients With Waldenstrom's Macroglobulinemia

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1738397

Intravenous immunoglobulin therapy in multifocal motor neuropathy: a double-blind, placebo-controlled study.

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1738397

Multifocal motor neuropathy improved by IVIg: randomized, double-blind, placebo-controlled study.

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1738397

Rituximab (IDEC-C2B8): validation of a sensitive enzyme-linked immunoassay applied to a clinical pharmacokinetic study.

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1738397

Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1738397

Multifocal motor neuropathy: diagnosis and treatment

15 August 2018

1 reference

12 December 2020

Multifocal motor neuropathy. Serum IgM anti-GM1 ganglioside antibodies in most patients detected using covalent linkage of GM1 to ELISA plates

1 reference

12 December 2020

Long-term prognosis of neuropathy associated with anti-MAG IgM M-proteins and its relationship to immune therapies

1 reference

12 December 2020

Distal lower motor neuron syndrome with high-titer serum IgM anti-GM1 antibodies: improvement following immunotherapy with monthly plasma exchange and intravenous cyclophosphamide

1 reference

12 December 2020

Anti-MAG antibodies: major effects of antigen purity and antibody cross-reactivity on ELISA results and clinical correlation

1 reference

12 December 2020

1 reference

12 December 2020

Rituximab for myasthenia gravis developing after bone marrow transplant

1 reference

12 December 2020

Comparison of maximal voluntary isometric contraction and Drachman's hand-held dynamometry in evaluating patients with amyotrophic lateral sclerosis

1 reference

12 December 2020

Polyneuropathy attributes: a comparison between patients with anti-MAG and anti-sulfatide antibodies

1 reference

12 December 2020

Progression of multifocal motor neuropathy during apparently successful treatment with human immunoglobulin

1 reference

12 December 2020

Anti-MAG antibody-associated polyneuropathies: improvement following immunotherapy with monthly plasma exchange and IV cyclophosphamide

1 reference

12 December 2020

Immunosuppressive treatment in multifocal motor neuropathy

1 reference

12 December 2020

Severe sensory ataxia and demyelinating polyneuropathy with IgM anti-GM2 and GalNAc-GD1A antibodies

1 reference

12 December 2020

Identifiers

DOI

10.1136/JNNP.74.4.485

1 reference

13 November 2017

1 reference

13 November 2017

1 reference